Pharm-Rx Triclosan
- CAS Number
- 3380-34-5
- Chemical Name
- Triclosan
- Molecular Formula
- C₁₂H₇Cl₃O₂
Pharm-Rx Triclosan, serves as an essential component of pharmaceuticals as an active ingredient (API). Owing to its varied pharmacological properties, which render it essential for a range of formulations and therapeutic applications, it finds extensive application in the pharmaceutical industry.
Properties
- Physical Form
- Powder
Product families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Chemical Inventories
AICS (Australia), DSL (Canada), ECL (Korea), EINECS (EU), ENCS (Japan), IECSC (China), NZIoC (New Zealand), PICCS (Phillipines), TSCA (USA); AICS (Australia); DSL (Canada); ECL (Korea); EINECS (EU); ENCS (Japan); IECSC (China); NZIoC (New Zealand); PICCS (Phillipines); TSCA (USA)
- Certifications & Compliance
- DMF Type II, FDA 29 CFR 1910.1200
- Definition
Triclosan contains not less than 97.0% and not more than 103.0% of triclosan (C₁₂H₇Cl₃O₂), calculated on the anhydrous basis.
- Soluble In
- Acetone Soluble
- Ethanol Soluble
- Methanol Soluble
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- USP Reference Standards
USP 2,4-Dichlorophenol RS 2,4-Dichlorophenol; C6H4Cl2O 163.00 (USP 1-Dec-2021) USP Parachlorophenol RS 4-Chlorophenol; C6H5ClO 128.56 (USP 1-Dec-2021) USP Triclosan RS USP Triclosan Related Compounds Mixture A RS Contains a mixture of the following four compounds: 2,8-Dichlorodibenzofuran; 2,4,8-Trichlorodibenzofuran; 2,8-Dichlorodibenzodioxin; 1,3,7-Trichlorodibenzodioxin; (USP 1-Dec-2021)
- Certifications and Compliance
- DMF Type II
- FDA 29 CFR 1910.1200
Technical data
Table 1 of 1
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 289.54 |
